Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes

被引:76
|
作者
Smedby, Karin E. [1 ]
Hjalgrim, Henrik [2 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden
[2] State Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
关键词
Mantle cell lymphoma; Epidemiology; Etiology; Non-Hodgkin lymphoma; TUMOR-NECROSIS-FACTOR; POOLED ANALYSIS; FAMILY-HISTORY; INFLAMMATORY DISORDERS; FOLLICULAR LYMPHOMA; MALIGNANT-LYMPHOMA; UNITED-STATES; RISK-FACTORS; HEPATITIS-C; CANCER;
D O I
10.1016/j.semcancer.2011.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to give an overview of the descriptive epidemiology and etiology of mantle cell lymphoma (MCL) in the context of all non-Hodgkin lymphoma (NHL) and major NHL subtypes, based on available published reports. In retrospective case series, MCL cases represent between 2 and 10% of all NHL Population-based studies of MCL incidence by basic demographic characteristics are limited to the past 15-20 years and to Europe and the US. In both regions, average incidence rates of approximately 0.5 cases per 100 000 person-years were reported, with a male-to-female ratio of 2.3-2.5:1, and a median age at diagnosis of close to 70 years. Some data suggest a possible increase in MCL incidence over the last two decades, but the observation may also reflect improved diagnostics. The causes of MCL are not known. Studies of potential risk factors of MCL are few and conducted primarily within the framework of all NHL Moderate associations with MCL risk have been reported for Borrelia burgdorferi infection, family history of hematopoietic malignancies, and genetic variation in the interleukin-10 and tumor necrosis factor genes, but findings remain unconfirmed. Large multicenter studies are needed to address these and other factors in risk of MCL with sufficient statistical power in the future. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 50 条
  • [1] Epidemiology and etiology of non-Hodgkin lymphoma -: a review
    Ekström-Smedby, K
    [J]. ACTA ONCOLOGICA, 2006, 45 (03) : 258 - 271
  • [2] MANTLE CELL LYMPHOMA, AN UNCOMMON PRESENTATION OF NON-HODGKIN LYMPHOMA
    Fadeyi, Olaniyi
    Gupta, Lakshita
    Anugu, Gautam
    Hakim, Asaad
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (07) : 1614 - 1615
  • [3] The epidemiology of non-Hodgkin lymphoma
    Grulich, AE
    Vajdic, CM
    [J]. PATHOLOGY, 2005, 37 (06) : 409 - 419
  • [4] Epidemiology of Non-Hodgkin Lymphoma
    Skrabek, Pamela
    Turner, Donna
    Seftel, Matthew
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (02) : 133 - 138
  • [5] Epidemiology of adult non-Hodgkin lymphoma
    Boffetta, P.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 27 - 31
  • [6] The epidemiology of non-Hodgkin's lymphoma
    Fisher, SG
    Fisher, RI
    [J]. ONCOGENE, 2004, 23 (38) : 6524 - 6534
  • [7] The epidemiology of non-Hodgkin's lymphoma
    Susan G Fisher
    Richard I Fisher
    [J]. Oncogene, 2004, 23 : 6524 - 6534
  • [8] Advances in Classification and Treatment of Non-Hodgkin Lymphoma Mantle Cell
    Rule, Simon
    Johns, Sophie
    [J]. CANCER JOURNAL, 2020, 26 (04): : 348 - 356
  • [9] ETIOLOGY AND PATHOGENESIS OF NON-HODGKIN LYMPHOMA IN AIDS
    LUXTON, JC
    THOMAS, JA
    CRAWFORD, DH
    [J]. CANCER SURVEYS, 1991, 10 : 103 - 119
  • [10] Epidemiology of non-Hodgkin's lymphoma (NHL):: trends, geographic distribution, and etiology
    Müller, AMS
    Ihorst, G
    Mertelsmann, R
    Engelhardt, M
    [J]. ANNALS OF HEMATOLOGY, 2005, 84 (01) : 1 - 12